Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial updating efficacy and safety of once-daily tacrolimus in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplant | Phase 4 | Status: COMPLETED